20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Infusion dosage form of norepinephrine
#6902Emodin for Use in Regulating Expression of Proteins Involved in Inflammation
#6903Combinations of mRNAs encoding immune modulating polypeptides and uses thereof
#6904PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE
#6905MEDICAL INFUSION PUMP SYSTEM FOR THE DELIVERY OF AN INSULIN COMPOUND
#6906DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#6907S1PR2 ANTAGONISTS FOR TREATING DISEASES INVOLVING ABNORMAL IMMUNE RESPONSES
#6908Ruminant compositions
#6909FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
#6910PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES
#6911COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V BETA-3-POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT AND METASTATIC CANCERS
#6912METHODS FOR TREATING CANCER WITH BAVITUXIMAB BASED ON LEVELS OF BETA2-GLYCOPROTEIN 1, AND ASSAYS THEREFOR
#6913Methods of treating ulcerative colitis with an anti-IL-23p19 antibody
#6914Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
#6915Conformal coating of cells for immunoisolation
#6916Hydrogel prodrug for treatment
#6917ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
#6918HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
#6919Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)
#6920Liquid pharmaceutical composition
#6921DOSING REGIMEN FOR AN IDO INHIBITOR
#6922ADJUVANT COMPOSITION CONTAINING ALUMINUM AND VACCINE COMPOSITION CONTAINING THE SAME
#6923Bunyavirales vaccine
#6924COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#6925EXTRACELLULAR VESICLES COMPRISING TARGETING AFFINITY DOMAIN-BASED MEMBRANE PROTEINS
#6926METHODS FOR ADMINISTERING ANGIOTENSIN II
#6927METHODS FOR TREATMENT OF CANCER AND ENHANCEMENT OF NANOPARTICLE ACCUMULATION IN TISSUES
#6928INTRAPERITONEAL INJECTION OF HUMAN PLACENTA STEM CELLS PROTECT THE BRAIN FROM STROKE INJURY VIA EXOSOME/MICROPARTICLE FORMATION AND ACE2 MAINTENANCE OF BRAIN PERFUSION
#6929Compositions for use to treat cataract
#6930METHODS AND COMPOSITIONS FOR TREATING CANCER
#6931Compositions and methods of treating cancer
#6932Anesthetic mixtures formulations for local anesthesia, at very low concentration, to be used cold with suitable packaging
#6933RESTORATION OF TRANSMEMBRANE COPPER TRANSPORT
#6934GRP94 INHIBITORS TO TREAT STEROID-INDUCED OCULAR HYPERTENSIONS AND GLAUCOMAS
#6935Deoxyribonucleic acid nanoshells for co-delivering proteins and protein-containing compounds and methods of manufacturing deoxyribonucleic acid nanoshells containing proteins and protein-containing compounds
#6936Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
#6937Treatment of pneumonia
#6938SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS
#6939Hyperbranched polyglycerol-coated particles and methods of making and using thereof
#6940RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
#6941THERAPEUTIC TARGETING OF ONCOGENES USING EXOSOMES
#6942Anti-PfRH5 antibodies and antigen-binding fragments thereof
#6943Immunogenic peptide against group a
#6944TREATMENT OF MYOTONIC DYSTROPHY
#6945COMPOSITIONS AND METHODS FOR PEPTIDE MEDIATED OLIGONUCLEOTIDE DELIVERY TO THE CENTRAL NERVOUS SYSTEM
#6946Liquid pharmaceutical composition
#6947CANCER TREATMENTS
#6948IVIG treatments for Bell's palsy
#6949Methods for preventing dengue and hepatitis A
#6950Factor IX polypeptides and methods of use thereof
#6951DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 Fc FUSION PROTEINS
#6952ONCOLYTIC VACCINIA VIRUS EXPRESSING IMMUNE CHECKPOINT BLOCKADE FOR CANCER IMMUNOTHERAPY
#6953Intravenous injection for enhancing immune function
#6954Treatment of alphavirus-induced inflammation
#6955Continuous release compositions made from hyaluronic acid, and therapeutic applications of same
#6956TREATMENT OF CANCER BY SYSTEMIC ADMINISTRATION OF DBAIT MOLECULES
#6957Formulation for administration of RNA
#6958Compositions and methods for the treatment and prevention of muscular dystrophy
#6959Dosing regimens of PKC activators
#6960Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
#6961Adjusting particle size in fluorocarbon nanoemulsions
#6962Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#6963NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY
#6964SUSTAINED RELEASE TREPOSTINIL-COMPOUND MICROPARTICLE COMPOSITIONS
#6965BISPECIFIC BINDING AGENTS AND USES THEREOF
#6966Composition and method for inhibiting amyloid β accumulation and/or aggregation
#6967Nucleic acid aptamers to treat histone-induced disease states
#6968Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate
#6969Hemoglobin-based therapeutic agents
#6970Method of Treating Parkinson's Disease
#6971BIOORTHOGONAL COMPOSITIONS
#6972Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
#6973Anhydrous sodium thiosulfate and formulations thereof
#6974TREATMENT WITH ANTI-VEGF ANTIBODIES
#6975Vaccine delivery method
#6976METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF SEIZURES
#6977ENZYME REPLACEMENT THERAPY FOR MUCOPOLYSACCHARIDOSIS IIID
#6978TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6979TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6980METHODS AND COMPOSITIONS RELATING TO LUNG REPAIR
#6981Rescuing voltage-gated sodium channel function in inhibitory neurons
#6982Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal
#6983Plant medium including an oxygen-enabled composition
#6984Treatment of bone marrow edema (OEDEMA) with polysulfated polysaccharides
#6985Hydroxypropyl beta-cyclodextrin compositions and methods
#6986Compositions and methods for the treatment of a beta-catenin-associated disease or disorder
#6987Ready-to-administer fentanyl formulations
#6988Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
#6989Ifetroban Treatment for Systemic Sclerosis
#6990TREATMENT USING DANTROLENE
#6991Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid receptor antagonist
#6992Cannabidiol preparations and its uses
#6993Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
#6994Nitroxyl donors with improved therapeutic index
#6995Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders
#6996MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS
#6997Use of metformin and sodium butyrate for treating conditions induced by chronic inflammation
#6998Needle assisted jet injection administration of testosterone compositions
#6999Gene therapies for lysosomal disorders
#7000TREATMENT OF OCULAR DISEASES WITH HUMAN POST-TRANSLATIONALLY MODIFIED VEGF-TRAP
#7001Engineered vaccinia virus
#7002Cardiomyocyte preparation and preparation method therefor and use thereof
#7003ANGIOGENESIS-INDUCING METHOD USING NEURAL STEM CELL
#7004Models of tauopathy
#7005HM-3 fusion protein and application thereof
#7006COMPOUNDS AND METHODS FOR TREATING PAIN
#7007SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS
#7008Aminocoumarin compounds and methods of their use
#7009PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY
#7010Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
#7011ORGANIC COMPOUNDS
#7012CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF
#7013Methods for treating protozoan infections
#7014COMPOSITIONS AND METHODS FOR TREATING SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (SSADHD)
#7015BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#7016Nanostructured gels capable of controlled release of encapsulated agents
#7017Method for lyophilizing live vaccine strains of
#7018Autologous cancer vaccines
#7019METHODS OF INDUCING IMMUNE TOLERANCE AND REDUCING ANTI-DRUG ANTIBODY RESPONSE
#7020FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
#7021LONG-ACTING IGF-1 OR IGF-1 VARIANTS AND METHODS OF PRODUCING SAME
#7022Erythropoietin for Gastrointestinal Dysfunction
#7023Therapeutic vitamin D conjugates
#7024Formulations containing a somatostatin receptor agonist
#7025Compositions and methods for restoring or increasing tissue perfusion
#7026METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#7027METHODS FOR TREATING MUSCULAR DYSTROPHY
#7028Therapeutic agent for nervous system disease
#7029COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
#7030USE OF A BISPHOSPHONATE SALT IN A MEDICAMENT FOR A NATURALLY OCCURRING DISEASE/DISORDER IN A MAMMAL
#7031System and method for diagnosis and treatment
#7032Biomarkers of methotrexate-induced immune tolerance
#7033Use of CDK9 inhibitors to reduce cartilage degradation
#7034COMPOSITIONS AND METHODS FOR CANCER TREATMENT
#7035LIQUID FORMULATIONS OF BENDAMUSTINE
#7036Means to facilitate food intake and food retention
#7037HEPATOPROTECTENT PHENYLBUTYRATYRATE DRUG CONJUGATES, AND THEIR COMPOSITIONS PREPARATION AND METHODS OF USE THEREOF
#7038Methods of treating the deleterious effects of excessive use of drugs and alcohol
#7039Methods for treating mucopolysaccharidosis
#7040COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE
#7041NANOPARTICLE COMPOSITIONS
#7042Nanoparticle-based liver-targeting therapy
#7043IMMUNO-EXOSOMES AND METHODS OF USE THEREOF
#7044Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
#7045SOLUTIONS COMPRISING OZONIZED OIL
#7046LIPOSOMAL SPHERICAL NUCLEIC ACID (SNA) CONSTRUCTS FOR SURVIVAL OF MOTOR NEURON (SMA) INHIBITORS
#7047Pharmaceutical composition for preventing or treating angiogenesis relating ocular diseases comprising inhibitors of MCT expression or activity
#7048DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#7049ANTI-PD-1 ANTIBODY COMPOSITIONS
#7050Glucagon-like peptides
#7051Crystal form of ethyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate hydrochloride
#7052Spiro-lactam NMDA modulators and methods of using same
#7053Antibacterial agents: soluble salts and aqueous formulations of pyronins
#7054Antibacterial agents: O-alkyl-deuterated pyronins
#7055Prodrug derivatives of protein kinase C modulators
#7056FOCAL PHOTODYNAMIC THERAPY METHODS
#7057Electrostatic drug delivery
#7058Electrostatic drug delivery
#7059INCLUSION COMPLEXES SUITABLE FOR USE AS A HISTOTRIPSY AGENT
#7060Ophthalmic compositions, and ocular uses thereof, of indigo carmine
#7061Nucleic acid products and methods of administration thereof
#7062Use of anti-HER2 antibody-drug conjugate in cancer treatment
#7063STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF IN MEDICINE
#7064USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS
#7065COMBINATION THERAPIES
#7066COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
#7067TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#7068METHODS AND COMPOSITION FOR THE TREATMENT OF ALLERGIC ASTHMA
#7069COMPOSITIONS AND METHODS FOR PROTECTING EPITHELIAL AND BARRIER INTEGRITY
#7070HMGB1 antagonist treatment of severe sepsis
#7071MODULATION OF HSD17B13 EXPRESSION
#7072Prostate Cancer Specific Marrow Infiltrating Lymphocytes and Uses Thereof
#7073ENGINEERED METAL NANOPARTICLES AND METHODS THEREOF
#7074Composition for use in the treatment of conditions caused by calcium deficiency
#7075Treatment of post-operative joint pain with polysulfated polysaccharides
#7076Stem cell-derived exosomes for the treatment of corneal scarring
#7077Intermittent dosing of MDM2 inhibitor
#7078Nicotinamide riboside treatments of domesticated meat animals
#7079Methods and compositions for treatment of epileptic disorders
#7080Isoflavonoid compounds and methods for the treatment of cancer
#7081NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#7082Taxane particles and their use
#7083THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID
#7084DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#7085Spermine pro-drugs
#7086Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin
#7087Polymer particles for neutrophil injury
#7088DRUG DELIVERY FORMULATIONS
#7089Method to prepare pharmaceutical compositions of suggamadex
#7090VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS
#7091Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
#7092Anti-ANGPT2 antibodies
#7093HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
#7094Ultra-long acting insulin-Fc fusion proteins and methods of use
#7095Ultra-long acting insulin-Fc fusion proteins and methods of use
#7096Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating thereto
#7097METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON
#7098ETANERCEPT FORMULATIONS STABILIZED WITH XYLITOL
#7099LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB
#7100Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
#7101Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor
#7102Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor
#7103Human alpha-galactosidase variants
#7104Methods and compositions for CNS delivery of arylsulfatase A
#7105A HEPATOCYTE-MIMICKING ANTIDOTE FOR ALCOHOL INTOXICATION
#7106Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#7107TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#7108GHRH or analogues thereof for use in treatment of hepatic disease
#7109SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#7110COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS
#7111PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING ANTICANCER VIRUS AND HYDROXYUREA AS EFFECTIVE COMPONENTS
#7112METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS
#7113ADMINISTRATION OF FIBROBLASTS AND DERIVATIVES THEREOF FOR TREATMENT OF TYPE 2 DIABETES
#7114Macrophage-based therapy
#7115Method of treating severe forms of pulmonary hypertension
#7116Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid
#7117S-antigen transport inhibiting oligonucleotide polymers and methods
#7118METHOD OF TREATING HYPERTENSION
#7119Compounds and methods for treating nematode infections
#7120USE OF ISOXAZOLINE COMPOUNDS FOR TREATING DEMODICOSIS
#7121Taxane Particles and Their Use
#7122Extended duration local anesthetic formulation
#7123Methods and compositions for treating and preventing arthritis
#7124PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS
#7125INJECTABLE COMPOSITION FOR PREVENTING HAIR LOSS OR STIMULATING HAIR GROWTH
#7126METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY
#7127Treatment of diabetes mellitus
#7128Humanized BCMA antibody and BCMA-CAR-T cells
#7129Compositions and methods for treating pain in subjects with rheumatoid arthritis
#7130Methods and compositions for preventing type 1 diabetes
#7131Pharmaceutical formulations of FcRn inhibitors suitable for subcutaneous administration
#7132THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#7133Fosnetupitant chloride hydrochloride having improved stability
#7134Multivalent ligand for myotonic dystrophy
#7135Cyclopentaimidazolones for the treatment of cancer
#7136Prodrugs of fencamfamine
#7137HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS
#7138BSH complex for boron neutron capture therapy
#7139Radioluminescent Nanoparticles for Radiation-Triggered Controlled Release Drugs
#7140Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
#7141Combination product for use in tumor vaccination
#7142Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
#7143Long lasting effect of new botulinum toxin formulations
#7144High frequency application of botulinum toxin therapy
#7145COMPOSITIONS AND METHODS FOR TREATING MPSI
#7146Recombinant alkaline phosphatase for use in treating sepsis-associated acute kidney injury
#7147TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#7148TREATING ROTATOR CUFF CONDITIONS
#7149Reconstituted HDL formulation
#7150METHODS AND COMPOSITIONS FOR PROMOTING OPC DIFFERENTIATION AND REMYELINATION USING RECEPTOR ASSOCIATED PROTEIN (RAP)
#7151DOSING REGIMENS FOR CELIAC DISEASE
#7152COMPOSITION COMPRISING THE EXTRACT OF HERBS FOR PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS
#7153INJECTABLE FORMULATIONS FOR TREATING CANCER
#7154Formulation comprising a gemcitabine-prodrug
#7155TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
#7156PREVENTION OF HIV-INFECTION
#7157Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
#7158Stable nimodipine parenteral formulation
#7159STABLE NIMODIPINE PARENTERAL FORMULATION
#7160PARENTERAL FORMULATION MATERIALS AND METHODS FOR 40-O-CYCLIC HYDROCARBON ESTERS AND RELATED STRUCTURES
#7161Cyclocreatine phosphate: a novel bioenergetic therapy to prevent and treat ischemia-induced and aging-related cardiovascular and neurodegenerative diseases
#7162TUMESCENT CONTRAVENOM DRUG DELIVERY
#7163COMPOSITIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE WITH A CANNABINOID RECEPTOR ANTAGONIST
#7164Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis
#7165Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
#7166Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same
#7167IMMUNOMODULATING TREATMENTS OF BODY CAVITIES
#7168Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis
#7169Therapeutic dendrimer
#7170T cell-antigen coupler with Y182T mutation and methods and uses thereof
#7171Antibodies to human B7x for treatment of metastatic cancer
#7172METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
#7173Methods for treating systemic sclerosis
#7174ANTIBODY FORMULATION
#7175TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
#7176Stabilized liquid anti-RSV antibody formulations
#7177Polypeptides and medical uses thereof
#7178Composition comprising hyaluronic acid and mepivacaine
#7179ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY CONTRAST AGENTS
#7180KNOTTIN-DRUG CONJUGATES AND METHODS OF USING THE SAME
#7181Methods for enhancing antigen-specific immune responses
#7182BOTULINUM TOXIN FORMULATIONS AND METHODS OF USE THEREOF IN PLANTAR FASCITIS WITH EXTENDED DURATION OF EFFECT
#7183Rusalatide acetate compositions
#7184Treatment of Short Bowel Syndrome Patients with Colon-in-Continuity
#7185METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS
#7186Pharmaceutical formulations of C1 esterase inhibitor
#7187Composition and method for treating osteoarthritis with manganese dioxide nanoparticles
#7188Nanoclays for the control of melanoma cell proliferation and cell viability
#7189Methods and systems for modulating cellular activation
#7190Anionically charged chitosan
#7191Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations
#7192Association of actives for treating prostate cancer
#7193Methods and compositions of bile acids and salts for reduction of fat
#7194Compositions and methods for treating ovarian tumors
#7195Pharmaceutical combinations for use in the treatment of neoplastic diseases
#7196Myrcene-containing complex mixtures targeting TRPV1
#7197Drug-loaded microbead compositions, embolization compositions and associated methods
#7198Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#7199RADIATION SENSITIZER OF ANTI-CANCER CHEMOTHERAPY SENSITIZER
#7200Micro-RNA profiling, compositions, and methods of treating diseases